Navigating Treatment Options for Relapsed CLL

This chapter explores various treatment strategies for relapsed chronic lymphocytic leukemia (CLL), focusing on PI3K and BTK inhibitors while considering their side effects. It emphasizes the importance of patient prognosis in treatment decisions and highlights critical markers associated with CLL management.